Phospholipid profiles and hepatocellular carcinoma risk and prognosis in cirrhotic patients-Reference-Cited by-同舟云学术

Phospholipid profiles and hepatocellular carcinoma risk and prognosis in cirrhotic patients

Published:2019-03-15 Issue:22 Volume:10 Page:2161-2172
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Cotte Alexia Karen¹²,Cottet Vanessa¹³⁴,Aires Virginie¹²,Mouillot Thomas⁵,Rizk Maud¹³,Vinault Sandrine¹⁴,Binquet Christine¹³⁵,de Barros Jean-Paul Pais¹⁶,Hillon Patrick¹³⁵,Delmas Dominique¹²

Affiliation:

1. University of Bourgogne, Franche-Comté, Dijon, France

2. INSERM U1231 “Lipids, Nutrition, Cancer”, Research Team Cancer and Adaptive Immune Response (CADIR), Dijon, France

3. INSERM U1231 “Lipids, Nutrition, Cancer”, Research Team Epidemiology and Clinical Research in Digestive Oncology (EPICAD), Dijon, France

4. Inserm, Clinical Investigation Center, Dijon, France

5. Department of Hepatogastroenterology, University Hospital, Dijon, France

6. Lipidomic Platform, Dijon, France

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of membrane physiology in sHSP Lo18-lipid interaction and lipochaperone activity;Scientific Reports;2024-07-24

2. Diagnostic and prognostic potential of tissue phospholipidomics in hepatocellular carcinoma: A prospective cohort study;2024-03-20

3. Molecular and Metabolic Phenotyping of Hepatocellular Carcinoma for Biomarker Discovery: A Meta-Analysis;Metabolites;2023-10-27

4. Biomarker Discovery for Hepatocellular Carcinoma in Patients with Liver Cirrhosis Using Untargeted Metabolomics and Lipidomics Studies;Metabolites;2023-10-02

5. Reprogramming of lipid metabolism in hepatocellular carcinoma resulting in downregulation of phosphatidylcholines used as potential markers for diagnosis and prediction;Expert Review of Molecular Diagnostics;2023-09-06